| Literature DB >> 25889625 |
Gaëtan-Romain Joliat1, Emmanuel Melloul2, Reza Djafarrian3, Sabine Schmidt4, Sara Fontanella5, Pu Yan6, Nicolas Demartines7, Nermin Halkic8.
Abstract
BACKGROUND: Cystic lymphangioma is a rare tumor of the lymphatic vessels that occurs more frequently in women. Location of this pathology can be diverse but most commonly occurs in the neck or axilla. Cystic lymphangioma originating from the adrenal tissue represents a very rare entity. CASEEntities:
Mesh:
Year: 2015 PMID: 25889625 PMCID: PMC4335415 DOI: 10.1186/s12957-015-0490-0
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Figure 1Magnetic resonance (MR) imaging of the cystic lymphangioma. Coronal (a) T2-weighted turbo spin-echo and axial (b) T1-weighted contrast-enhanced gradient-echo MR images show an ovoid left adrenal lesion (arrow). It is homogeneously hyperintense on T2-weightening (a) and hypointense on T1-weightening (b), thus confirming the fluid content without loculation neither solid component. The thin wall surrounding the lesion is barely perceptible.
Figure 2Pathological macroscopic image. Macroscopic views of the resected adrenal specimen measuring 8.5 × 4.3 × 2.8 cm.
Figure 3Histological view of the cystic lymphangioma of the left adrenal gland (hematoxylin and eosin staining, 40×).
Figure 4Immunohistochemistry images. D2-40 (a), PROX1 (b), CD31 (c), CD34 (d), and CKAE1/AE3 (e) immunohistochemical stains.
Cases of cystic lymphangioma of the adrenal gland reported in the English-written literature from 2000
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| 1 | Akand et al. [ | 2013 | 1 | F | 44 | O | Pain | L |
| 2 | Sourial et al. [ | 2013 | 1 | F | 52 | L |
| L |
| 3 | Makni et al. [ | 2012 | 2 | F/M | 40/40 | O/L |
| 2 L |
| 4 | Ellis et al. [ | 2011 | 9 | 6 F/3 M | 28 to 56a | Not precised | 5 | 6 R/3 L |
| 5 | Chien et al. [ | 2008 | 8 | 6 F/2 M | 31 to 59a | Not precised | 4 | 4 R/4 L |
| 6 | Bettaïeb et al. [ | 2007 | 1 | F | 22 | Not precised | Pain | L |
| 7 | Ates et al. [ | 2005 | 1 | F | 26 | O | Weakness | R |
| 8 | Garcia et al. [ | 2004 | 1 | F | 22 | Not precised | Pain | R |
| 9 | Longo et al. [ | 2000 | 1 | F | 30 | O | Pain | R |
| 10 | Trojan et al. [ | 2000 | 1 | M | 40 | Not precised |
| R |
aRange; bhypertension.